The use of hematopoietic stem cells in autoimmune diseases

被引:11
作者
Ben Nasr, Moufida [1 ,2 ]
Bassi, Roberto [1 ,2 ]
Usuelli, Vera [2 ]
Valderrama-Vasquez, Alessandro [2 ]
Tezza, Sara [1 ]
D'Addio, Francesca [1 ,2 ]
Fiorina, Paolo [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Nephrol Div, Boston Childrens Hosp, Boston, MA USA
[2] IRCCS Osped San Raffaele, Transplant Med Div, Milan, Italy
关键词
autoimmune diseases; hematopoietic stem cells; Type; 1; diabetes; BONE-MARROW-TRANSPLANTATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NONOBESE DIABETIC MICE; TOTAL-BODY IRRADIATION; ZEALAND BLACK MICE; PROGENITOR CELLS; TOLERANCE INDUCTION; RECENT-ONSET; NOD MICE; PULSE CYCLOPHOSPHAMIDE;
D O I
10.2217/rme-2015-0057
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Hematopoietic stem cells (HSCs) have been shown recently to hold much promise in curing autoimmune diseases. Newly diagnosed Type 1 diabetes individuals have been successfully reverted to normoglycemia by administration of autologous HSCs in association with a nonmyeloablative regimen (antithymocyte globulin + cyclophasmide). Furthermore, recent trials reported positive results by using HSCs in treatment of systemic sclerosis, multiple sclerosis and rheumatoid arthritis as well. Early data suggested that HSCs possess immunological properties that may be harnessed to alleviate the symptoms of individuals with autoimmune disorders and possibly induce remission of autoimmune diseases. Mechanistically, HSCs may facilitate the generation of regulatory T cells, may inhibit the function of autoreactive T-cell function and may reshape the immune system.
引用
收藏
页码:395 / 405
页数:11
相关论文
共 107 条
[1]   Immunomodulation by mesenchymal stem cells - A potential therapeutic strategy for type 1 diabetes [J].
Abdi, Reza ;
Fiorina, Paolo ;
Adra, Chaker N. ;
Atkinson, Mark ;
Sayegh, Mohamed H. .
DIABETES, 2008, 57 (07) :1759-1767
[2]   Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice [J].
Ansaria, Mohammed Javeed I. ;
Fiorina, Paolo ;
Dada, Shirine ;
Guleria, Indira ;
Ueno, Takuya ;
Yuan, Xueli ;
Trikudanathan, Subbulaxmi ;
Smith, R. Neal ;
Freeman, Gordon ;
Sayegh, Mohamed H. .
CLINICAL IMMUNOLOGY, 2008, 126 (02) :140-147
[3]   Haematopoietic cell transplantation as immunotherapy [J].
Appelbaum, FR .
NATURE, 2001, 411 (6835) :385-389
[4]   Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease-Is It Now Ready for Prime Time? [J].
Atkins, Harold L. ;
Muraro, Paolo A. ;
van Laar, Jacob M. ;
Pavletic, Steven Z. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) :S177-S183
[5]   Inflammatory signals regulate hematopoietic stem cells [J].
Baldridge, Megan T. ;
King, Katherine Y. ;
Goodell, Margaret A. .
TRENDS IN IMMUNOLOGY, 2011, 32 (02) :57-65
[6]   Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection [J].
Baldridge, Megan T. ;
King, Katherine Y. ;
Boles, Nathan C. ;
Weksberg, David C. ;
Goodell, Margaret A. .
NATURE, 2010, 465 (7299) :793-U9
[7]   Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice [J].
Beilhack, GF ;
Scheffold, YC ;
Weissman, IL ;
Taylor, C ;
Jerabek, L ;
Burge, MJ ;
Masek, MA ;
Shizuru, JA .
DIABETES, 2003, 52 (01) :59-68
[8]   Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site [J].
Ben Nasr, Moufida ;
Vergani, Andrea ;
Avruch, James ;
Liu, Liye ;
Kefaloyianni, Eirini ;
D'Addio, Francesca ;
Tezza, Sara ;
Corradi, Domenico ;
Bassi, Roberto ;
Valderrama-Vasquez, Alessandro ;
Usuelli, Vera ;
Kim, James ;
Azzi, Jamil ;
El Essawy, Basset ;
Markmann, James ;
Abdi, Reza ;
Fiorina, Paolo .
ACTA DIABETOLOGICA, 2015, 52 (05) :917-927
[9]   Novel therapies for T1D on the horizon [J].
Ben Nasr, Moufida ;
Fiorina, Paolo .
PHARMACOLOGICAL RESEARCH, 2015, 98 :1-2
[10]   The rise, fall, and resurgence of immunotherapy in type 1 diabetes [J].
Ben Nasr, Moufida ;
D'Addio, Francesca ;
Usuelli, Vera ;
Tezza, Sara ;
Abdi, Reza ;
Fiorina, Paolo .
PHARMACOLOGICAL RESEARCH, 2015, 98 :31-38